46,XX pure gonadal dysgenesis with growth hormone deficiency and impaired 3 beta-hydroxysteroid dehydrogenase activity.
Patients with 46,XX pure gonadal dysgenesis generally are of normal stature and have less than usual amounts of pubic and axillary hair. We report on a patient who presented at age 11.9 years with short stature, absence of breast development, and excessive pubic hair. Her karyotype in leukocytes, fibroblasts, and streak gonad was 46,XX. The patient was diagnosed as having growth hormone deficiency. Elevated ACTH stimulated levels of 17-hydroxypregnenolone and dehydroepiandrosterone and elevated ACTH stimulated ratio of 17-hydroxypregnenolone to 17-hydroxyprogesterone suggested inadequate adrenal 3 beta-hydroxysteroid dehydrogenase activity. Treatment with growth hormone resulted in improvement in growth velocity and replacement with estrogen in feminization. We suggest that the finding of short stature in patients with 46,XX pure gonadal dysgenesis should not be attributed to the syndrome, but rather requires investigation for possible growth hormone deficiency. The poor growth of our patient prior to growth hormone replacement implies that dehydroepiandrosterone, unlike testosterone and estrogen, is ineffective in promoting linear growth in the absence of adequate growth hormone.
Sills
I N
IN
Children's Hospital of New Jersey, Newark 07107.
Rapaport
R
R
Skuza
K A
KA
Horlick
M N
MN
D015096:3-Hydroxysteroid Dehydrogenases / Q000172:deficiency*; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D005260:Female; D006059:Gonadal Dysgenesis / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D006130:Growth Disorders / Q000150:complications / Q000235:genetics / Q000378:metabolism; D013006:Growth Hormone / Q000172:deficiency*; D006801:Humans; D010641:Phenotype; D014770:Virilism / Q000150:complications / Q000235:genetics
D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D015096:3-Hydroxysteroid Dehydrogenases